Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

12.74

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

EPS Last/This Y

0.15

EPS This/Next Y

0.04

Price

1.36

Target Price

3.6

Analyst Recom

2

Performance Q

7.09

Relative Volume

1.06

Beta

0.6

Ticker: GERN




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13GERN1.150.060.4794309
2025-11-14GERN1.120.0616.9595867
2025-11-17GERN1.1350.117.81100004
2025-11-18GERN1.10.151.71103901
2025-11-19GERN1.0850.160.08105567
2025-11-20GERN1.1050.160.83105643
2025-11-21GERN1.120.160.00106171
2025-11-24GERN1.1550.170.36100870
2025-11-25GERN1.1550.160.01100844
2025-11-26GERN1.190.160.43100757
2025-12-01GERN1.1950.160.01103540
2025-12-02GERN1.240.160.02103566
2025-12-03GERN1.2750.160.00103863
2025-12-04GERN1.2650.160.00103731
2025-12-05GERN1.3150.160.01104213
2025-12-08GERN1.2650.160.77104709
2025-12-09GERN1.230.210.01114469
2025-12-10GERN1.2950.210.00114576
2025-12-11GERN1.380.210.01114526
2025-12-12GERN1.360.210.21114603
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-13GERN1.150.8-8.8-0.14
2025-11-14GERN1.12-12.4-12.9-0.14
2025-11-17GERN1.1315.7-17.5-0.12
2025-11-18GERN1.1015.7-12.8-0.12
2025-11-19GERN1.0815.7-13.2-0.12
2025-11-20GERN1.1115.7-17.6-0.12
2025-11-21GERN1.121.7-17.6-0.12
2025-11-24GERN1.151.7-18.4-0.12
2025-11-25GERN1.161.7-15.0-0.12
2025-11-26GERN1.201.7-19.1-0.12
2025-12-01GERN1.201.7-17.4-0.12
2025-12-02GERN1.231.7-18.2-0.12
2025-12-03GERN1.271.7-18.9-0.12
2025-12-04GERN1.261.7-15.4-0.12
2025-12-05GERN1.311.7-18.6-0.12
2025-12-08GERN1.271.7- -0.12
2025-12-09GERN1.231.7-13.6-0.12
2025-12-10GERN1.231.7-20.7-0.12
2025-12-11GERN1.391.7-22.0-0.12
2025-12-12GERN1.361.7-13.9-0.12
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13GERN0.04-0.2514.10
2025-11-14GERN0.00-0.2514.06
2025-11-17GERN0.000.5814.12
2025-11-18GERN0.000.5814.12
2025-11-19GERN0.000.5814.12
2025-11-20GERN0.000.5814.12
2025-11-21GERN0.000.5814.12
2025-11-24GERN0.00-1.0014.04
2025-11-25GERN0.00-1.0014.04
2025-11-26GERN0.00-1.0012.78
2025-12-01GERN0.00-1.0412.78
2025-12-02GERN0.00-1.0412.78
2025-12-03GERN0.00-1.0412.78
2025-12-04GERN0.00-1.0412.78
2025-12-05GERN0.00-1.0412.78
2025-12-08GERN0.00-1.0612.78
2025-12-09GERN0.00-1.0612.78
2025-12-10GERN0.00-1.0612.74
2025-12-11GERN0.00-1.0612.74
2025-12-12GERN0.00-1.0612.74
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="GERN" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

Institutional Transactions

-1.06

Beta

0.6

Average Sales Estimate Current Quarter

50

Average Sales Estimate Next Quarter

53

Fair Value

Quality Score

47

Growth Score

56

Sentiment Score

40

Actual DrawDown %

74.5

Max Drawdown 5-Year %

-79

Target Price

3.6

P/E

Forward P/E

PEG

P/S

4.73

P/B

3.49

P/Free Cash Flow

EPS

-0.12

Average EPS Est. Cur. Y​

-0.12

EPS Next Y. (Est.)

-0.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-43.61

Relative Volume

1.06

Return on Equity vs Sector %

-59.1

Return on Equity vs Industry %

-44.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-13.9
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”GERN” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Geron Corporation
Sector: Healthcare
Industry: Biotechnology
Employees: 229
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
stock quote shares GERN – Geron Corporation Stock Price stock today
news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch GERN – Geron Corporation yahoo finance google finance
stock history GERN – Geron Corporation invest stock market
stock prices GERN premarket after hours
ticker GERN fair value insiders trading